Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco van Doorn

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Pigment Cell & Melanoma Research|August 9, 2020
Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanomaEirini Christodoulou, Mamunur Rashid, Clare Pacini, et al.
The Journal of Investigative Dermatology|April 27, 2016
Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic MarkersRemco van Doorn, Roderick C Slieker, Stéphanie E Boonk, et al.
Journal of Medical Genetics|October 7, 2018
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline <i>CDKN2A</i> mutationsHildur Helgadottir, Paola Ghiorzo, Remco van Doorn, et al.
The Journal of Investigative Dermatology|April 20, 2012
A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoidesMarloes S van Kester, Martin K Borg, Willem H Zoutman, et al.
Cancer Research|June 8, 2026
Spatial Analysis Reveals Gene Expression and Microenvironmental Changes in the Transition of Nevus to MelanomaInger Z M Kreuger, Veerle A Merkus, Sanne de Haan, et al.
The Journal of Investigative Dermatology|July 8, 2014
Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancyLinda Gao, Karin van den Hurk, Peter T M Moerkerk, et al.
Molecular Oncology|March 17, 2011
miRNA expression profiling of mycosis fungoidesMarloes S van Kester, Erica Ballabio, Marchina F Benner, et al.
Annals of Neurology|April 23, 2025
Association Between Vascular NOTCH3 Aggregation and Disease Severity in a CADASIL Cohort - Implications for NOTCH3 Variant-Specific Disease PredictionMinne N Cerfontaine, Gido Gravesteijn, Remco J Hack, et al.
Journal of Medical Genetics|April 18, 2018
CM-Score: a validated scoring system to predict <i>CDKN2A</i> germline mutations in melanoma families from Northern EuropeThomas P Potjer, Hildur Helgadottir, Mirjam Leenheer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2005
Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73Remco van Doorn, Willem H Zoutman, Remco Dijkman, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Pigment Cell & Melanoma Research|August 9, 2020
Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanomaEirini Christodoulou, Mamunur Rashid, Clare Pacini, et al.
The Journal of Investigative Dermatology|April 27, 2016
Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic MarkersRemco van Doorn, Roderick C Slieker, Stéphanie E Boonk, et al.
Journal of Medical Genetics|October 7, 2018
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline <i>CDKN2A</i> mutationsHildur Helgadottir, Paola Ghiorzo, Remco van Doorn, et al.
The Journal of Investigative Dermatology|April 20, 2012
A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoidesMarloes S van Kester, Martin K Borg, Willem H Zoutman, et al.
Cancer Research|June 8, 2026
Spatial Analysis Reveals Gene Expression and Microenvironmental Changes in the Transition of Nevus to MelanomaInger Z M Kreuger, Veerle A Merkus, Sanne de Haan, et al.
The Journal of Investigative Dermatology|July 8, 2014
Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancyLinda Gao, Karin van den Hurk, Peter T M Moerkerk, et al.
Molecular Oncology|March 17, 2011
miRNA expression profiling of mycosis fungoidesMarloes S van Kester, Erica Ballabio, Marchina F Benner, et al.
Annals of Neurology|April 23, 2025
Association Between Vascular NOTCH3 Aggregation and Disease Severity in a CADASIL Cohort - Implications for NOTCH3 Variant-Specific Disease PredictionMinne N Cerfontaine, Gido Gravesteijn, Remco J Hack, et al.
Journal of Medical Genetics|April 18, 2018
CM-Score: a validated scoring system to predict <i>CDKN2A</i> germline mutations in melanoma families from Northern EuropeThomas P Potjer, Hildur Helgadottir, Mirjam Leenheer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2005
Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73Remco van Doorn, Willem H Zoutman, Remco Dijkman, et al.
Pageof 12